牛皮研究的进展:解码免疫电路和开发新疗法
Lanying Wang1,2, Ruiling Liu1,2, Yulu Tang1,2
1Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine, Kaifeng 475004, China.
International journal of molecular sciences
|September 27, 2025
概括
牛皮是一种自身免疫性皮肤疾病,涉及IL-23/IL-17轴和免疫细胞相互作用. 新兴疗法对长期缓解有希望,但需要进一步研究以获得最佳的安全性和有效性.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 自身免疫性疾病是一种自身免疫性疾病.
- 慢性炎症状况 慢性炎症状况
背景情况:
- 牛皮是一种慢性自身免疫性皮肤疾病,具有影响生活质量的全身并发症.
- 疾病的发病包括IL-23/IL-17轴,免疫细胞失调,遗传因素和环境触发因素.
- 目前的治疗方法提供症状控制,但不能治愈,面临成本,安全,疗效和目标精度方面的挑战.
研究的目的:
- 审查最近关于牛皮的机制性见解,重点关注微生物,先天性和适应性免疫的相互作用.
- 评估牛皮的新兴疗法,包括生物药物,小分子,CAR T细胞疗法和RNA干扰策略.
- 评估这些新方法在个性化治疗和实现长期缓解方面的潜力.
主要方法:
- 关于牛皮研究近期进展的综合文献综述.
- 对新兴疗法的新机制,疗效,安全性和准准确性的分析.
- 对 psoriasis 管理的个性化药物策略的评估.
主要成果:
- IL-23/IL-17轴和免疫细胞相互作用是牛皮发育的核心.
- 新兴疗法展示了新的机制,但在有效性,安全性和精度方面存在挑战.
- 个性化治疗方法有可能实现长期的牛皮缓解.
结论:
- 了解微生物和免疫的相互作用对于牛皮的发病过程至关重要.
- 新兴疗法为牛皮管理提供了新的途径,需要仔细评估.
- 精准医学方法对于未来的牛皮治疗和实现持续缓解至关重要.
相关概念视频
EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
The JAK-STAT Signaling Pathway
12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.1K

